Market revenue in 2023 | USD 74.5 million |
Market revenue in 2030 | USD 473.1 million |
Growth rate | 30.2% (CAGR from 2024 to 2030) |
Largest segment | Oncology |
Fastest growing segment | Infectious Disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.42% in 2023. Horizon Databook has segmented the Canada artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing implementation of AI in drug discovery owing to its benefits, such as facilitating drastically greater speed and capacity, can lead to major advancements in healthcare, where researchers often struggle to make sense of the vast quantities of complex data.
This is anticipated to contribute to market growth in the country. Growing investments in AI in healthcare by the Canadian government is also fueling the market in Canada. According to Canadian Healthcare Technology, in June 2018, the Canadian government invested USD 24.9 million to launch a research program in AI and healthcare.
Furthermore, increasing investments by the government in AI have created several opportunities in the country, such as the availability of 1,000 middle-class jobs and a new source of economic growth to make economies more competitive, inclusive, and sustainable.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Canada artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account